SynergyFinder Plus: Toward Better Interpretation and Annotation of Drug Combination Screening Datasets
2022 · Genomics Proteomics & Bioinformatics · 599 citations
https://doi.org/10.1016/j.gpb.2022.01.004
Z
Ziaurrehman Tanoli
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
70
Papers
2.5K
Citations
18
h-index
28
i10-index
Ziaurrehman Tanoli is an academic researcher from University of Helsinki. The author has contributed to research in topics: Computational Drug Discovery Methods & Bioinformatics and Genomic Networks & Biomedical Text Mining and Ontologies. The author has an h-index of 18, co-authored 60 publications.
ORCID: 0000-0003-2435-9862Papers by this author
worksCrowdsourced mapping of unexplored target space of kinase inhibitors
2021 · Nature Communications · 88 citations
https://doi.org/10.1038/s41467-021-23165-1
A community challenge for a pancancer drug mechanism of action inference from perturbational profile data
2022 · Cell Reports Medicine · 65 citations
https://doi.org/10.1016/j.xcrm.2021.100492
“Be sustainable”: <scp>EOSC‐Life</scp> recommendations for implementation of <scp>FAIR</scp> principles in life science data handling
2023 · The EMBO Journal · 24 citations
https://doi.org/10.15252/embj.2023115008
Validation guidelines for drug-target prediction methods
2024 · Expert Opinion on Drug Discovery · 24 citations
https://doi.org/10.1080/17460441.2024.2430955
Multi‐modal meta‐analysis of cancer cell line omics profiles identifies ECHDC1 as a novel breast tumor suppressor
2021 · Molecular Systems Biology · 18 citations
https://doi.org/10.15252/msb.20209526
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat